Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

Wellbutrin Dosage: SR, XL, and the 450 mg Ceiling

Clinically reviewed by Elizabeth Lokenauth, PA-C, CAQ-Psy

Reviewed November 5, 2026 · Last updated November 5, 2026

Key Takeaways

  • Wellbutrin XL usually starts at 150 mg once each morning and can rise to a usual target of 300 mg after 4 days.
  • Wellbutrin SR starts at 150 mg a day, usually targets 150 mg twice daily, and tops out at 400 mg a day, with no single dose above 200 mg.
  • 450 mg a day is the maximum recommended bupropion dose. Seizure risk is about 0.1% at SR doses up to 300 mg and rises almost tenfold between 450 and 600 mg.
  • Higher doses bring more side effects. In SR trials, insomnia affected 16% of people at 400 mg versus 11% at 300 mg and 6% on placebo.
  • Liver disease, eating disorders, seizure history, and some interacting drugs can lower your safe dose or rule bupropion out.

Your prescription says 150 mg. A friend takes 300. Someone online swears by 450, and this month’s pharmacy bottle says XL while the last one said SR. When depression has already drained your energy, the last thing you need is a dosing puzzle with no explanation attached.

Bupropion, the medicine in Wellbutrin, works differently from SSRIs. The Wellbutrin XL label describes it as a relatively weak blocker of norepinephrine and dopamine reuptake that doesn’t affect serotonin. Your liver converts it into active metabolites, and the labels cap both single doses and daily totals to keep blood levels from peaking too high, because seizure risk rises with dose. That’s why bupropion dosing demands precision: small, timed steps toward the dose your brain needs.

The standard approach works. A 2016 meta-analysis of 51 studies found that the more rigorous trials support bupropion over placebo, that it performs about as well as other antidepressants head to head, and that it causes very little sexual dysfunction. The results are real, and the science is well established.

But a dose chart doesn’t tell you why the limits sit where they do, and at Siggy we’d rather you understand the reasoning behind your dose than simply follow a number.

Nearly every Wellbutrin limit traces back to one fact: seizure risk rises with dose, slowly at first and then steeply. The XL label reports a seizure rate of about 0.1% at sustained-release doses up to 300 mg a day and an estimate that climbs almost tenfold between 450 and 600 mg a day. Knowing where that curve bends turns your dose into a decision grounded in pharmacology.

What This Page Covers

What Is the Usual Wellbutrin Dose?

For depression, most people start at 150 mg a day. The XL label recommends 150 mg once each morning, with an increase to the usual target of 300 mg once daily possible after 4 days. The label tells prescribers to increase the dose gradually to reduce seizure risk.

Wellbutrin XL is also approved to prevent seasonal depression. For seasonal affective disorder, treatment starts in autumn at 150 mg, may rise to 300 mg after 7 days, continues through winter, and tapers in early spring. Doses above 300 mg weren’t tested in those trials.

Bupropion builds up in your body over about a week. The label puts its average half-life at 21 hours and says steady blood levels arrive within 8 days. If you switch from Wellbutrin SR to XL, the label recommends keeping the same total daily dose when possible.

How Do Wellbutrin SR and XL Doses Compare?

SR and XL deliver the same medicine, but their schedules and ceilings differ, as shown in the Wellbutrin SR label and the Forfivo XL label alongside the XL label. A pharmacokinetic review of bupropion confirms the formulations are bioequivalent, with XL absorbed most slowly, reaching peak levels in about 5 hours compared with about 3 hours for SR.

Version How Often Usual Target Daily Maximum
Wellbutrin SR Twice daily, 8+ hours apart 300 mg 400 mg
Wellbutrin XL Once daily, morning 300 mg 300 to 450 mg
Forfivo XL Once daily 450 mg only 450 mg

One wrinkle is worth knowing. The current Wellbutrin XL label lists 300 mg as the usual target and, in its seizure section, says the dose should not exceed 300 mg once daily, while other parts of the same label describe 450 mg a day as the limit that keeps seizure risk down. Either way, higher doses are a step for people who haven’t responded at 300 mg. The SR label allows 400 mg a day, given as 200 mg twice daily, only after several weeks at 300 mg without improvement. Forfivo XL is meant for people who have taken 300 mg a day for at least 2 weeks and need 450 mg. For a closer look at schedules, see our guide to Wellbutrin SR vs XL.

Why Is 450 mg the Ceiling?

Seizure risk isn’t a straight line. According to the XL label, studies of sustained-release bupropion up to 300 mg a day found seizures in about 1 in 1,000 people. A large follow-up study of immediate-release bupropion at 300 to 450 mg a day found about 4 in 1,000 (13 of 3,200 people). Between 450 and 600 mg a day, the estimated rate rises almost tenfold.

The SR label shows the same curve at a lower ceiling: about 0.1% at doses up to 300 mg and about 0.4% at 400 mg a day. The Forfivo XL label notes that 600 mg is twice the usual adult dose, and calls the disproportionate jump in seizures a reason for caution.

Keep those numbers in perspective. A review of antidepressants and seizures estimated the risk with newer antidepressants, including bupropion, at 0.0% to 0.4%, compared with a first-seizure rate of 0.07% to 0.09% in the general population. At standard doses in people without risk factors, seizures are rare. The ceiling exists to keep it that way.

Does a Higher Dose Work Better?

Sometimes. In one of the original immediate-release trials described in the SR label, 450 mg a day separated from placebo while 300 mg did not, though another trial confirmed 300 mg was effective. Some people need more than 300 mg, and many don’t.

At usual doses, bupropion holds its own. A pooled analysis of 7 trials found remission rates of 47% with bupropion and 47% with SSRIs, compared with 36% on placebo, and bupropion caused no more sexual dysfunction than placebo.

Side effects climb with dose. The SR label’s placebo-controlled trials show the trade-off.

Side Effect Placebo SR 300 mg SR 400 mg
Insomnia 6% 11% 16%
Dry mouth 7% 17% 24%
Agitation 2% 3% 9%
Nausea 8% 13% 18%
Stopped due to side effects 4% 9% 11%

If you’re tolerating 300 mg well but still feel depressed after several weeks, a dose increase is one reasonable conversation. If side effects are already a problem, a higher dose may make things worse.

Who Needs a Lower Dose?

Some people shouldn’t take bupropion at all. The XL label lists contraindications including a seizure disorder, current or past bulimia or anorexia nervosa, abruptly stopping alcohol, benzodiazepines, barbiturates, or antiepileptic drugs, and taking an MAOI within 14 days. The eating disorder warning has a long history: a 1989 review of bulimia research noted an apparently higher seizure rate in people with bulimia treated with bupropion, a finding the authors called unexplained.

Other factors raise seizure risk and call for extra caution, according to the label: severe head injury, severe stroke, a brain tumor or infection, diabetes treated with insulin or oral medication, excessive alcohol use, and other drugs that lower the seizure threshold, such as antipsychotics, tricyclic antidepressants, theophylline, and systemic corticosteroids.

Your liver and kidneys matter too. With moderate to severe liver impairment, the XL maximum is 150 mg every other day, and the SR maximum is 100 mg a day or 150 mg every other day. With kidney impairment, both labels advise considering a lower dose or less frequent dosing. Forfivo XL isn’t recommended with either condition because it comes in only one strength.

Which Drugs Change Your Wellbutrin Dose?

Bupropion is processed mainly by an enzyme called CYP2B6. The XL label reports that clopidogrel and ticlopidine raise bupropion exposure, while ritonavir, efavirenz, and possibly carbamazepine lower it. A dose increase may be needed with those enzyme boosters, but the label says the maximum should never be exceeded.

Bupropion also blocks another enzyme, CYP2D6, which can raise blood levels of some antidepressants, including fluoxetine, paroxetine, and sertraline, as well as the beta-blocker metoprolol. It can also cause a false-positive urine drug screen for amphetamines. Give your prescriber a full medication list, including supplements.

How Should You Take Wellbutrin?

Swallow SR and XL tablets whole. Both labels say not to crush, divide, or chew them, because that defeats the slow release. XL is taken in the morning, with or without food.

With SR, space your two doses at least 8 hours apart. To avoid high peak levels, the SR label says no single dose should exceed 200 mg, which is also why doubling up after a missed dose is a bad idea. Ask your pharmacist how to handle a missed dose.

Alcohol is a special concern. The label advises minimizing or avoiding it, and suddenly stopping heavy drinking while on bupropion raises seizure risk. Our guide to Wellbutrin and alcohol covers this in more depth.

How Do You Lower or Stop Your Dose?

Step down instead of stopping cold. For people taking 300 mg of XL, the label recommends dropping to 150 mg once daily before discontinuing. Our guide on how to taper off Wellbutrin walks through what that process can look like.

Any dose change, up or down, deserves closer attention. The label’s boxed warning advises monitoring for worsening mood or suicidal thoughts, especially in people under 25, and its warnings section singles out times of dose changes, whether increases or decreases. If you’re in crisis, call 911 or call or text 988.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including depression. If you’re weighing bupropion against other options, our guide to when doctors choose Wellbutrin over SSRIs walks through the trade-offs.

Siggy’s free, anonymous intake asks for no name, email, or account. You can describe your symptoms, your current medications and doses, and any history that affects seizure risk. The intake gathers structured information and doesn’t diagnose you on its own, and a licensed prescriber reviews it before anything is prescribed. Your downloadable summary lets you share that full picture with any clinician, so you don’t have to retell your story.

Siggy isn’t an emergency service. This article is for education and isn’t a substitute for advice from your own prescriber. It reflects sources available as of November 2026.

The Bottom Line on Wellbutrin Dosage

Most people take 150 to 300 mg of Wellbutrin a day, and the usual target for depression is 300 mg. The ceilings, 400 mg for SR and 450 mg overall, exist because seizure risk rises steeply above them, and higher doses also bring more insomnia, dry mouth, and agitation. Your safest dose depends on your health history, your other medications, and how you respond at each step, which is why the plan should be built with a prescriber who knows the whole picture. If side effects are what’s holding you back, our guide to Wellbutrin side effects covers what’s common and what’s worth a call.

Start Your Anonymous Intake

If you’re in crisis right now, call 911 or call or text 988 first. If you want a licensed prescriber to look at your symptoms, your medications, and the dose that fits your life, start your anonymous intake. It’s free, there’s no name or email required, and a licensed prescriber reviews your intake before anything is prescribed. Your summary is yours to keep and share with any clinician.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

What is the starting dose of Wellbutrin?

For depression, Wellbutrin XL and Wellbutrin SR both start at 150 mg a day taken in the morning. The XL label allows an increase to 300 mg once daily after 4 days, while the SR label allows 150 mg twice daily after 3 days, with at least 8 hours between doses. Your prescriber decides whether and when to go up.

What is the maximum dose of Wellbutrin?

The maximum recommended bupropion dose is 450 mg a day, and Wellbutrin SR has its own lower ceiling of 400 mg a day. The current Wellbutrin XL label is inconsistent, saying in one place not to exceed 300 mg once daily. The limits exist because seizure risk rises with dose. FDA labeling notes that the estimated seizure rate climbs almost tenfold between 450 and 600 mg a day.

Is 300 mg of Wellbutrin a high dose?

No. 300 mg a day is the usual target dose for depression with both Wellbutrin XL (300 mg once daily) and Wellbutrin SR (150 mg twice daily). Higher doses up to the labeled maximums are generally reserved for people who haven't improved after several weeks at 300 mg.

Can I take 450 mg of Wellbutrin XL at once?

Some people do, but only under a prescriber's direction. Forfivo XL, a single 450 mg extended-release tablet, is meant for people who have already taken 300 mg a day of bupropion for at least 2 weeks and need 450 mg. It can't be used to start treatment because no lower strength exists.

What happens if I miss a dose of Wellbutrin?

Don't double up. Wellbutrin's seizure risk is tied to high peak blood levels, which is why the SR label caps any single dose at 200 mg. If you miss a dose, ask your pharmacist or prescriber whether to skip it and resume your usual schedule.

Do I need a lower dose of Wellbutrin with liver or kidney problems?

Often, yes. With moderate to severe liver impairment, the Wellbutrin XL maximum is 150 mg every other day, and the SR maximum is 100 mg a day or 150 mg every other day. With kidney impairment, labels advise considering a lower dose or less frequent dosing.

Sources

  1. Bausch Health US. WELLBUTRIN XL (bupropion hydrochloride extended-release tablets) prescribing information (NDA 021515), revised February 2026. DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov
  2. Patel K, Haque MN, Angelescu I, et al. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Therapeutic Advances in Psychopharmacology. 2016;6(2):99-144. doi:10.1177/2045125316629071
  3. GlaxoSmithKline. WELLBUTRIN SR (bupropion hydrochloride sustained-release tablets) prescribing information (NDA 020358), revised November 2025. DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov
  4. Upsher-Smith Laboratories. FORFIVO XL (bupropion hydrochloride extended-release tablets) prescribing information (NDA 022497), revised November 2025. DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov
  5. Montgomery SA. Antidepressants and seizures: emphasis on newer agents and clinical implications. International Journal of Clinical Practice. 2005;59(12):1435-1440. doi:10.1111/j.1368-5031.2005.00731.x
  6. Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clinical Therapeutics. 2005;27(11):1685-1695. doi:10.1016/j.clinthera.2005.11.011
  7. Thase ME, Haight BR, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. Journal of Clinical Psychiatry. 2005;66(8):974-981. doi:10.4088/jcp.v66n0803
  8. Horne RL, Pope HG, McElroy SL, et al. Electrophysiologic abnormalities in bulimia and their implications for pharmacotherapy: a reassessment. International Journal of Eating Disorders. 1989;8(2):191-201. doi:10.1002/1098-108X(198903)8:2<191::AID-EAT2260080208>3.0.CO;2-L